Myths vs facts: COMT and Blutzucker

The link between COMT (especially the Val158Met polymorphism, rs4680) and blood sugar is a topic with conflicting evidence. COMT breaks down catecholamines like adrenaline, which can raise blood glucose via glycogenolysis and gluconeogenesis. The theory: carriers of the Met variant (low enzyme activity) may have higher catecholamine levels, potentially leading to elevated fasting glucose or insulin resistance. Some cross-sectional studies have found weak associations, but others have not. Importantly, the effects are small, overshadowed by lifestyle factors (diet, stress, exercise), and have no clinical relevance for diabetes diagnosis. A genetic test for COMT alone is not suitable for predicting or managing blood sugar issues. MyBody-X tests that include COMT should be interpreted as part of a broader picture, not as standalone decision tools. Evidence: mechanistic and mixed. Caveat: no validated clinical application for blood sugar.